Scammers are using fake traffic violation texts with QR codes to steal personal and financial data, posing as state courts ...

I don't care what your teachers said: You can wait until the last minute to study and still ace your test. You just need the right study guide. Enter: Today's FBT Newsletter. Scott White, Frank ...

SALINAS – The city of Salinas is seeking public input as it charts the course of the city’s future with the Vision Salinas 2040 Updated General Plan. The public is invited to join an open house ...

If you’ve noticed it’s more difficult to focus on objects up close as you age, you’re not alone. Approximately 128 million Americans suffer from a common form of vision loss—and the number is only ...

After months of workforce reductions and sliding equipment sales, John Deere is reversing course, announcing it will bring 140 employees back to its Waterloo, Iowa, operations as demand ticks higher ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The FDA has approved YUVEZZI, the first dual-agent eye drop, to treat presbyopia, a leading cause of vision loss in adults. The medication uses a fixed-dose combination of carbachol (2.75%) and ...

What Is Yuvezzi, and Why Does It Matter? Yuvezzi is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you age. It's the only ...

On today’s highly observant episode of Quick Charge, Waymo founder John Krafcik takes aim at Tesla’s Full Self Driving hardware limitations and Volvo Cars rolls out their most important new product of ...

Adam Dubis, PhD, is driving advances for artificial intelligence in eye care and vision research. Adam Dubis, PhD. John A. Moran Eye Center researcher Adam Dubis, PhD, works at the intersection of big ...

Add Yahoo as a preferred source to see more of our stories on Google. USC Roski Eye Institute researchers are launching a phase 2b trial of a stem cell retinal implant designed to replace damaged ...

Tom Aspinall appears fed up with Ciryl Gane, and promises to get one back when they meet inside the octagon again. Their first meeting for the heavyweight title at UFC 321 ended abruptly in the first ...